Jane Street’s Immunic IMUX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$169K Buy
+18,200
New +$250K ﹤0.01% 10212
2026
Q2
– Sell
-1,510
Closed -$16.8K – 12307
2026
Q1
$16.8K Buy
+1,510
New +$13.5K ﹤0.01% 11224
2023
Q1
– Sell
-5,190
Closed -$72.7K – 9440
2022
Q4
$72.7K Buy
+5,190
New +$142K ﹤0.01% 8245

Other funds holding IMUX

Jane Street's IMUX Position: Q3 2026 in Review

Jane Street increased its Immunic (IMUX) stake by 139% in Q3 2026, buying an estimated $1.71M and bringing the position to 214,163 shares worth $1.99M. The position accounts for ﹤0.01% of the portfolio, ranked #5167.

Jane Street first reported a position in IMUX in Q2 2014 and has held it in 25 quarters since. 77 funds tracked by Wall St. Rank hold IMUX as of Q3 2026.

  • Jane Street held 214,163 shares of Immunic worth $1.99M as of Q3 2026.
  • Jane Street bought 124,476 Immunic shares in Q3 2026, an estimated $1.71M.
  • Immunic made up ﹤0.01% of Jane Street's portfolio in Q3 2026, its #5167 holding.
  • Jane Street first reported a position in Immunic in Q2 2014 and has held it in 25 quarters since.
  • 77 funds tracked by Wall St. Rank held Immunic as of Q3 2026.

Based on Jane Street's 13F filing for Q3 2026, filed 12 Nov 2026.